home / stock / dxr / dxr news

DXR News and Press, Daxor Corporation From 09/26/23

Stock Information
Company Name: Daxor Corporation
Stock Symbol: DXR
Market: NYSE
Website: daxor.com
Menu
DXR DXR Quote DXR Short DXR News DXR Articles DXR Message Board
Get DXR Alerts

News, Short Squeeze, Breakout and More Instantly...
DXR - DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE FALL'23 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR'S BLOOD VOLUME DIAGNOSTIC (BVA-100®)

The Premier Event for The Cardiovascular Industry's Leading Network of Executives and Clinicians - Transforming Cardiovascular Care Through Sharing Best Practices and Organizational Performance Solutions Oak Ridge, TN, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NA...
DXR - Daxor Corporation Awarded $305K Grant from the National Institutes of Health to Develop Blood Volume Guidance Software in Sepsis Patients

Oak Ridge, TN, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Daxor C orporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announced that the National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) has award...

DXR - Daxor Corporation to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Oak Ridge, TN, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh will present at the H.C. Wainwright 25th Annual Global Investment Conference being held on Se...

DXR - Daxor Corporation Reports a 20.64 Percent Increase in Diagnostic Test Kits Revenue From Prior Year Period in Form N-CSR Filing for the Six Months Ended June 30, 2023

Net Assets Increases to $30.4 Million From $29.0 Million Oak Ridge, TN, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR) , the global leader in blood volume measurement technology, announces today it filed Form N-CSR disclosing its schedule of portfolio holdings f...
DXR - JACC-HF Reports Successful Heart Failure Trial With Daxor BVA-100®

Researchers Call for Larger Clinical Trial Citing Outcomes from Study Oak Ridge, TN, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces a research letter in the Journal of the American Co...

DXR - JACC-HF Study Compares Daxor's BVA-100® Volume Metric to CardioMEMS® Pressure Metric in Heart Failure Patients

Volume and Pressure Measures are Complementary, Not Interchangeable Oak Ridge, TN, July 12, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces a new research letter in the Journal of the Ameri...

DXR - Daxor Corporation Announces Further Acquisitions and Increased Utilization of its BVA-100® Blood Volume Diagnostic Throughout the U.S.

Daxor Adds a Six-Facility Hospital System with ezBVA Lab and Expands Treatment Areas Among Existing Accounts Oak Ridge, TN, July 11, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces ex...
DXR - Daxor gets $1.1M contract from the US Defense Health Agency

2023-07-05 08:32:44 ET United States Defense Health Agency (or DHA) has awarded Daxor a $1.1M sequential Phase II Small Business Innovative Research (SBIR) contract to add the capability of electronic medical record (EMR) integration to its small, portable, highly accurate, battery-po...

DXR - Daxor Corporation Awarded $1.1 Million Contract from the United States Defense Health Agency for Added Capabilities to its Point-of-Care Blood Volume Analyzer

Oak Ridge, TN, July 05, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announced that the United States Defense Health Agency (DHA) has awarded the Company a $1.1 million sequential Phase II Small Business In...

DXR - Daxor Corporation Announces Partial Exercise of Over-Allotment Option in Secondary Offering

Oak Ridge, TN, June 22, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announced that Maxim Group LLC (“Maxim”), as Representative of several Underwriters of its previously announced secondary publi...
Previous 10 Next 10